Correlation Between Lineage Cell and ImmuCell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lineage Cell and ImmuCell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lineage Cell and ImmuCell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lineage Cell Therapeutics and ImmuCell, you can compare the effects of market volatilities on Lineage Cell and ImmuCell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lineage Cell with a short position of ImmuCell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lineage Cell and ImmuCell.

Diversification Opportunities for Lineage Cell and ImmuCell

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Lineage and ImmuCell is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Lineage Cell Therapeutics and ImmuCell in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ImmuCell and Lineage Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lineage Cell Therapeutics are associated (or correlated) with ImmuCell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ImmuCell has no effect on the direction of Lineage Cell i.e., Lineage Cell and ImmuCell go up and down completely randomly.

Pair Corralation between Lineage Cell and ImmuCell

Given the investment horizon of 90 days Lineage Cell Therapeutics is expected to under-perform the ImmuCell. In addition to that, Lineage Cell is 5.15 times more volatile than ImmuCell. It trades about -0.15 of its total potential returns per unit of risk. ImmuCell is currently generating about 0.11 per unit of volatility. If you would invest  357.00  in ImmuCell on August 29, 2024 and sell it today you would earn a total of  13.00  from holding ImmuCell or generate 3.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Lineage Cell Therapeutics  vs.  ImmuCell

 Performance 
       Timeline  
Lineage Cell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lineage Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
ImmuCell 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ImmuCell has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, ImmuCell is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Lineage Cell and ImmuCell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lineage Cell and ImmuCell

The main advantage of trading using opposite Lineage Cell and ImmuCell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lineage Cell position performs unexpectedly, ImmuCell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ImmuCell will offset losses from the drop in ImmuCell's long position.
The idea behind Lineage Cell Therapeutics and ImmuCell pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity